Ledger.Open graph →
SEC Form D · filed March 24, 2015

Aeglea BioTherapeutics, Inc

Offering
$44.0M
Sold
$44.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUSTIN, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

David G. Lowe · Austin, TXExec · DirectorArmen G. Shanafelt · Austin, TXDirectorCharles N. York · Austin, TXExecHenry G. Skinner · Austin, TXDirectorGeorge G. Georgiou · Austin, TXDirectorCharles N. York · Austin, TXExecDavid G. Lowe · Palo Alto, CAExec · DirectorHenry G. Skinner · Austin, TXDirectorGeorge G. Georgiou · Austin, TXDirectorArmen G. Shanafelt · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗